This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Humanising and dehumanising pigs in genomic and transplantation research
History and Philosophy of the Life Sciences Open Access 22 November 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cooper, D.K.C., Ye, Y., Rolf, J.L.L. & Zuhdi, N. The pig as potential organ donor for man in Xenotransplantation: The Transplantation of Organs and Tissues Between Species (eds Cooper, D.K.C., Kemp, E., Reemtsma, K. & White, D.J.G.) 481–500 (Springer, Berlin, 1991).
Calne, R.Y. Organ transplantation between widely disparate species. Transplants Proc. 2, 550–553 (1970).
Sachs, D.H. & Bach, F.H. Immunology of xenograft rejection. Hum. Immun. 28, 245–251 (1990).
Dalmasso, A.P. et al. Mechanisms of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am. J. Pathol. 140, 1157–1166 (1992).
Johnston, P.S., Wang, M.W., Lim, S.M., Wright, L.J. & White, D.J. Discordant xenograft rejection in an antibody-free model. Transplantation 54, 573–576 (1992).
Platt, J.L. et al. Immunopathology of hyperacute rejection in a swine to primate model. Transplantation 52, 214–220 (1991).
Kemp, E., Kemp, G., Starklint, H. & Larsen, S. Immunosuppression with cobra venom factor, anti-platelet aggregator, and cyclosporin A in renal xenotransplantation. Transplantn Proc. 14, 116 (1982).
Braidley, P.C., Dunning, J.J., Wallwork, J. & White, D.J.G. Prolongation of survival of rat heart xenografts in C3-deficient guinea pigs. Transplantn Proc. 26, 1259–1260 (1994).
Leventhal, J.R. et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 55, 857–865 (1993).
Pruitt, S.K. et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57, 363–370 (1994).
Lachmann, P.J. The control of homologous lysis. Immun. Today. 12, 312–315 (1991).
Atkinson, J.P., Odlesby, T.J., White, D.J.G., Adams, E.A. & Liszewski, M.K. Separation of self from non self in the complement system. A role for membrane cofactor protein and decay accelerating factor. Clin. exp. Immun. 86, 27–30 (1991).
Oglesby, T.J., Allen, C.J., Liszewski, M.K., White, D.J. & Atkinson, J.P. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J. exp. Med. 175, 1547–1551 (1992).
White, D.J.G. et al. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement. Transplant. Int. 5, 648–650 (1992).
Dalmasso, A.P., Vercelloti, G.M., Platt, J.L. & Bach, F.H. Inhibition of complement mediated cytotoxicity by decay accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 52, 530–533 (1991).
Cary, N., Moody, J., Yannoutsos, N., Wallwork, J. & White, D. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: A potential approach to inhibition of hyperacute xenograft rejection. Transplantn Proc. 25, 400–401 (1993).
Diamond, L. et al. Cell and tissue specific expression of a human CD59 minigene in transgenic mice. Transplantn Proc. 26, 1239 (1994).
Rosengard, A.M. et al. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs — a potential approach for preventing xenograft rejection. Transplantation 59, 1325–1333 (1995).
Fodor, W.L. et al. Expression of a functional human complement inhibitor in transgenic swine as an approach to prevent xenogeneic hyperacute organ rejection. Proc. natn. Acad. Sci. USA. 91, 11153–11157 (1994).
Miyagawa, S. et al. Effect of transfectant molecules, MCP, DAF, and MCP/DAF hybrid on xenogeneic vascular endothelium. Transplantn Proc. 26, 1253–1254 (1994).
Walsh, L.A., Tone, M. & Waldmann, H. Transfection of human CD59 complementary DNA into rat cells confers resistance to human complement. Eur. J. Immun. 21, 847–850 (1991).
Charreau, B. et al. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor. Transplantation 58, 1222–1229 (1994).
Van den Berg, C.W. & Morgan, B.P. Complement-inhibiting activities of human CD59 and analogues from rat, sheep and pig are not homologously restricted. J. Immun. 152, 4095–4101 (1995).
Langford, G.A. et al. Production of pigs transgenic for human decay accelerating factor. Transplantn Proc. 26, 1400–1401 (1994).
White, D.J.G., Langford, G.A., Cozzi, E. & Young, V.J. Protective effects of human DAF in transgenic pigs. Xeno (in the press).
McCurry, K.R. et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med. 1, 423–427 (1995).
Bach, F.H. et al. Discordant xenografting: A working model of problems and issues. Xeno 1, 8–15 (1993).
Cooper, D.K.C., Koren, E. & Oriol, R. Oligosaccharides and discordant xenotransplantation. Immunol. Rev. 141, 31–58 (1994).
Sandrin, M.S., Vaughan, H.A. & McKenzie, I.F.C. Identification of Galα(l–3)Gal as the major epitope for pig-to-human vascularised xenografts. Transplantn Rev. 8, 134–149 (1994).
Yannoutsos, N. et al. Production of pigs transgenic for human regulators of complement activation. Transplantn Proc. 27, 324–325 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cozzi, E., White, D. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1, 964–966 (1995). https://doi.org/10.1038/nm0995-964
Issue Date:
DOI: https://doi.org/10.1038/nm0995-964
This article is cited by
-
Progress in xenotransplantation: overcoming immune barriers
Nature Reviews Nephrology (2022)
-
Humanising and dehumanising pigs in genomic and transplantation research
History and Philosophy of the Life Sciences (2022)